This assay is to provide LNCaP-based In Vitro Tumor Cell Target Expression Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LNCaP
Target Cell Organism
Human
Target Cell Background
The LNCaP cell line was originally isolated from the lymph node of a patient with metastatic prostate cancer. Many cell lines have been derived from LNCaP by selective pressures to study different aspects of prostate cancer progression.
Related Diseases
Prostate Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Tumor Cell Target Expression Assay
Short Description
LNCaP-cell based In Vitro Tumor Cell Target Expression Assay